
The maker of ZYN nicotine pouches can tell consumers its products are safer to use than cigarettes, the Food and Drug Administration announced Tuesday. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. The agency has authorized Swedish Match USA, Inc., which is part of Philip Morris International, to say that 20 of its ZYN products “put you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis” than cigarettes.
Main Idea: The FDA said Swedish Match USA can market some ZYN nicotine pouches as less risky than cigarettes, but the move comes with limits and a warning about youth use.
Key Points:
FDA approval may make ZYN seem safe, which could raise nicotine use among teens and other users and create more addiction risk.
The FDA limit to selected flavors and strengths may steer some adults toward a less harmful choice than cigarettes.
Rate how each entity in this article affected the American people.
No entity suggestions or linked entities saved yet.
Central regulator that authorized the reduced-risk marketing claim for ZYN nicotine pouches.
Manufacturer receiving FDA authorization to market ZYN products as lower risk than cigarettes.
Major advocacy group publicly condemning the FDA’s action and calling for reversal.
Parent company of Swedish Match USA and a major accountable corporate actor behind ZYN.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment